Showing results (1471-1480 of 3,551) with videos related to

Sort By:
Pageof 356
Thoracic Cancer|June 5, 2019
The prognostic value of the preoperative albumin to alkaline phosphatase ratio in patients with non-small cell lung cancer after surgeryLianmin Zhang, Hua Zhang, Dongsheng Yue, et al.
Thoracic Cancer|June 12, 2019
Salvage treatment with anlotinib for advanced non-small cell lung cancerDi Wu, Jun Nie, Ling Dai, et al.
Thoracic Cancer|October 13, 2018
Value of the preoperative neutrophil-to-lymphocyte ratio as a prognostic factor for long-term survival in postoperative esophageal squamous cell carcinoma patientsGuang-Wen Xu, Han-Ran Wu, Ran Xiong, et al.
Thoracic Cancer|April 10, 2019
Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune-related adverse effect: A case reportRyuya Edahiro, Mikako Ishijima, Hiroyuki Kurebe, et al.
Thoracic Cancer|April 12, 2019
Successful treatment with nivolumab for SMARCA4-deficient non-small cell lung carcinoma with a high tumor mutation burden: A case reportTomoyuki Naito, Shigeki Umemura, Hiroshi Nakamura, et al.
Thoracic Cancer|October 21, 2021
Identification and validation of an individualized prognostic signature of lung squamous cell carcinoma based on ferroptosis-related genesXiayao Diao, Chao Guo, Lei Liu, et al.
Thoracic Cancer|September 28, 2021
Inflammation-nutritional markers of peripheral blood could predict survival in advanced non-small-cell lung cancer patients treated with PD-1 inhibitorsDan Pu, Qian Xu, Lai-Yan Zhou, et al.
Thoracic Cancer|September 29, 2021
Tolerability and efficacy of IMpower133 regimen modified for dialysis patients with extensive-stage small cell lung cancer: Two case reportsNaokazu Watari, Kakuhiro Yamaguchi, Takeshi Masuda, et al.
Thoracic Cancer|October 6, 2021
Lung squamous cell carcinoma with hemoptysis after vaccination with tozinameran (BNT162b2, Pfizer-BioNTech)Toshiyuki Sumi, Yuta Nagahisa, Keigo Matsuura, et al.
Thoracic Cancer|October 8, 2021
Small cell transformation in crizotinib-resistant ROS1-rearranged non-small cell lung cancer with retention of ROS1 fusion: A case reportChi-Hao Wu, Po-Lan Su, Che-Wei Hsu, et al.
Pageof 356